Yüklüyor......
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Background/Aim: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One drug that has attracted interest is the antiparasitic compound ivermectin, a macrocyclic lactone derived from the bacterium Streptomyces avermitili...
Kaydedildi:
| Yayımlandı: | In Vivo |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
International Institute of Anticancer Research
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652439/ https://ncbi.nlm.nih.gov/pubmed/32871846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12134 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|